GEM2014MAIN, NCT02406144 / 2014-000554-10: Trial Studying Maintenance Treatment With Lenalidomide and Dexamethasone Versus Lenalidomide, Dexamethasone and MLN9708 After Autologous Hematopoietic Stem Cell Transplantation in Patients With Newly-diagnosed Symptomatic Multiple Myeloma |
|
|
| Completed | 3 | 316 | Europe | MLN9708, Lenalidomide, Dexamethasone | PETHEMA Foundation, Celgene, Millennium Pharmaceuticals, Inc. | Multiple Myeloma | 09/17 | 11/17 | | |
